HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 71.28 +1.66 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.62 | 52 Week High | $18.39 | |||
| Open | $70.12 | 52 Week Low | $6.96 | |||
| Day High | $71.87 | P/E | N/A | |||
| Day Low | $69.73 | EPS | $-0.58 | |||
| Volume | 1,180,173 | |||||
